resources
AstraZeneca SCISSOR Summary of Journal of Controlled Release article 2025


Video
Preview - This content has been restricted to logged in users only.
Watch a summary of AstraZeneca’s study using SCISSOR to predict subcutaneous bioavailability and explore IVIVC for monoclonal antibodies.
Video
Listen to Pion’s Development Scientist, Conor Gomes summarize arecent publication by AstraZeneca in the Journal of Controlled Release where they used SCISSOR to investigate in vitro – in vivo correlations: ‘Predicting human subcutaneous bioavailability of monoclonal antibodies using an integrated in-vitro/in silico approach’
